Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage

Francesco Marampon; Giovanni Gravina; Xiaoming Ju; Antonella Vetuschi; Roberta Sferra; Mathew C. Casimiro; Simona Pompili; Claudio Festuccia; Alessandro Colapietro; Eugenio Gaudio; Ernesto Di Cesare; Vincenzo Tombolini; Richard G. Pestell

doi:10.18632/oncotarget.6579

journal article Dec 12, 2015

Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage

Francesco Marampon Giovanni Gravina Xiaoming Ju Antonella Vetuschi Roberta Sferra Mathew C. Casimiro Simona Pompili Claudio Festuccia Alessandro Colapietro Eugenio Gaudio Ernesto Di Cesare

Vincenzo Tombolini

Richard G. Pestell

Oncotarget Vol. 7 No. 5 pp. 5383-5400 · Impact Journals, LLC

View at Publisher Save 10.18632/oncotarget.6579

Topics

No keywords indexed for this article. Browse by subject →

References

50

[1]

Pickles "Radiation therapy in prostate cancer: a risk-adapted strategy" Curr Oncol (2010) 10.3747/co.v17i0.704

[2]

Antonarakis "Management of Biochemically Recurrent Prostate Cancer After Local Therapy: Evolving Standards of Care and New Directions" Clin Adv Hemat Oncol (2013)

[3]

Chen "The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy" Endoc Relat Canc (2007) 10.1677/erc-07-0073

[4]

Batra "Current status of the molecular genetics of human prostatic adenocarcinomas" Int J Cancer (2003) 10.1002/ijc.10813

[5]

Lobrich "Pathways of DNA double-strand break repair during the mammalian cell cycle" Mol Cell Biol (2003) 10.1128/mcb.23.16.5706-5715.2003

[6]

Kupiec "The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle" EMBO (2004) 10.1038/sj.emboj.7600469

[7]

Xia "Ionizing radiation-induced DNA damage, response, and repair" Antioxid Redox Signal (2014) 10.1089/ars.2013.5668

[8]

Yan "Radiation-induced signaling pathways that promote cancer cell survival (review)" Int J Oncol (2014) 10.3892/ijo.2014.2614

[9]

O'Neill "Biological consequences of radiation-induced DNA damage: relevance to radiotherapy" Clin Oncol (2013) 10.1016/j.clon.2013.06.007

[10]

Raghavan "DNA double-strand break repair inhibitors as cancer therapeutics" Chem Biol (2015) 10.1016/j.chembiol.2014.11.013

[11]

Tomkinson "Targeting abnormal DNA double strand break repair in cancer" Cell Mol Life Science (2010) 10.1007/s00018-010-0493-5

[12]

Draetta "Cyclin D1 is a nuclear protein required for cell cycle progression in G1" Genes Dev (1993) 10.1101/gad.7.5.812

[13]

Massague "G1 cell-cycle control and cancer" Nature (2004) 10.1038/nature03094

[14]

Pestell "New Roles of Cyclin D1" Am J Pathol (2013) 10.1016/j.ajpath.2013.03.001

[15]

Pestell "Minireview: Cyclin D1: Normal and Abnormal Functions" Endocrinology (2004) 10.1210/en.2004-0959

[16]

Pestell "Identification of a Cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint" Cancer Res (2014) 10.1158/0008-5472.can-13-1313

[17]

Pestell "Alternative Cyclin D1 splice forms differentially regulate the DNA damage response" Cancer Res (2010) 10.1158/0008-5472.can-10-0312

[18]

Pestell "Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity" Cancer Res (2005) 10.1158/0008-5472.can-05-0486

[19]

Beach "D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA" Cell (1992) 10.1016/0092-8674(92)90518-h

[20]

Sicinski "Proteomic identification of a direct role for Cyclin D1 in DNA damage repair" Cancer Res (2012) 10.1158/0008-5472.can-11-3549

[21]

A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers

Siwanon Jirawatnotai, Yiduo Hu, Wojciech Michowski et al.

Nature 2011 10.1038/nature10155

[22]

Pestell "Cyclin D1 integrates estrogen-mediated DNA damage repair signaling" Cancer Res (2014) 10.1158/0008-5472.can-13-3137

[23]

Jones "Establishment and characterization of a human prostatic carcinoma cell line (PC-3)" Invest Urol (1979)

[24]

Lucia "Molecular characterization of human prostate carcinoma cell lines" Prostate (2003) 10.1002/pros.10290

[25]

Beach "Myc confers androgen-independent prostate cancer cell growth" J Clin Invest (2003) 10.1172/jci200319035

[26]

Trono "Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference" J Virol (2003) 10.1128/jvi.77.16.8957-8951.2003

[27]

Festuccia "Hypoxiasustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay" Int J Oncol (2014) 10.3892/ijo.2014.2358

[28]

Zani "MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cellsandby downregulating growth and DNA repair signals" Mol Cancer Ther (2011) 10.1158/1535-7163.mct-10-0631

[29]

Coulombe "Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats" J Histochem Cytochem (1989) 10.1177/37.3.2465335

[30]

Chen "ErbB-2 induces the Cyclin D1 gene in prostate epithelial cellsand" Cancer Res (2007) 10.1158/0008-5472.can-06-1898

[31]

Conti "Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to Cyclin D1" Oncogene (1998) 10.1038/sj.onc.1201719

[32]

The extracellular matrix modulates the hallmarks of cancer

Michael W Pickup, Janna K Mouw, Valerie M Weaver

EMBO reports 2014 10.15252/embr.201439246

[33]

Pestell "Cyclin D1 functions in cell migration" Cell Cycle (2006) 10.4161/cc.5.21.3428

[34]

Pestell "Cyclin D1 governs adhesion and motility of macrophages" Mol Cell Biol (2003) 10.1091/mbc.02-07-0102

[35]

Burbelo "Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling" Mol Cell Biol (2006) 10.1128/mcb.02124-05

[36]

Pestell "Cyclin D1 induction of cellular migration requires p27(KIP1)" Cancer Res (2006) 10.1158/0008-5472.can-06-1596

[37]

Lu "Knockdown of Cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells" J Neurooncol (2012) 10.1007/s11060-011-0692-4

[38]

Sawa "Over-expression of Cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility" Int J Cancer (1999) 10.1002/(sici)1097-0215(19991029)83:3<387::aid-ijc15>3.0.co;2-o

[39]

Quong "Cyclin D1/cyclin-dependent kinase 4 interacts with Filamin A and affects the migration and invasion potential of breast cancer cells" Cancer Res (2010)

[40]

Pestell "PACSIN 2 represses cellular migration through direct association with Cyclin D1 but not its alternate splice form Cyclin D1b" Cell Cycle (2011) 10.4161/cc.10.1.14243

[41]

Pestell "microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling" Proc Natl Acad Sci U S A (2010) 10.1073/pnas.1002080107

[42]

Kim "Bcl-2 induces cyclin D1 promoter activity in human breast epithelial cells independent of cell anchorage" Cell Death Differ (2001) 10.1038/sj.cdd.4400770

[43]

Pestell "Cyclin D1 determines estrogen signaling in the mammary gland" Mol Endocrinol (2013) 10.1210/me.2013-1065

[44]

Folkman "“Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma”" Am J Pathol (1993)

[45]

Matsuura "Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization" Clin Cancer Res (2006) 10.1158/1078-0432.ccr-05-1213

[46]

Zhiping "Antisense to Cyclin D1 Inhibits VEGF-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization" Clin Cancer Res (2006) 10.1158/1078-0432.ccr-06-0614

[47]

Ross "Induction of cell death by radiotherapy" Endocr Relat Cancer (1999) 10.1677/erc.0.0060041

[48]

Kuo, Yang. Gamma-H2AX a novel biomarker for DNA double-strand breaks.In vivo. 2008; 22:305–9.

[49]

Tang "Cancer stem cells and radioresistance" Int J Radiat Biol (2014) 10.3109/09553002.2014.892227

[50]

Alberti "Prostate cancer: radioresistance molecular target-related markers and foreseeable modalities of radiosensitization" Eur Rev Med Pharmacol Sci (2014)

Metrics

48

Citations

50

References

Details

Published: Dec 12, 2015
Vol/Issue: 7(5)
Pages: 5383-5400

Authors

F

Francesco Marampon

University of L'Aquila, Department of Biotechnological and Applied Clinical Sciences, L'Aquila, Italy; Department of Cancer Biology, Medical Oncology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

G

Giovanni Gravina